Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Status:
Recruiting

Trial end date:
2025-12-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.

Phase 2

Kyowa Kirin, Inc.

Aflibercept